Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES (GILD)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales32 63930 39026 10721 37721 40322 050
EBITDA23 66820 34716 40512 74112 73913 284
Operating profit (EBIT)23 39620 03316 03111 22011 37011 974
Pre-Tax Profit (EBT)------
Net income18 10813 5014 6286 6507 1508 005
P/E ratio8,507,2020,415,013,812,2
EPS ( $ )11,99,943,515,045,486,19
Dividend per Share ( $ )1,291,842,082,272,462,63
Yield1,27%2,57%2,90%3,01%3,26%3,48%
Reference price ( $ )101.1971.6171.6475.5175.5175.51
Announcement Date02/02/2016
09:00pm
02/07/2017
09:01pm
02/06/2018
09:01pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt7 573-8 03212 36311 6101 441
Finance-32 380----
Operating income (EBITDA)23 66820 34716 40512 74112 73913 284
Leverage
(Debt/EBITDA)
0,32x-0,49x0,97x0,91x0,11x
Capital Expenditure747748590585655680
Book Value Per Share (BVPS)13,2 $14,6 $15,7 $20,2 $23,2 $25,1 $
Cash Flow per Share12,9 $12,3 $9,02 $7,84 $7,48 $8,07 $
Announcement Date02/02/2016
09:00pm
02/07/2017
09:01pm
02/06/2018
09:01pm
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 97 887 M$ -
Entreprise Value (EV) 110 250 M$ 109 497 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 15,0x 13,8x
Capitalization / Revenue 4,58x 4,57x
EV / Revenue 5,16x 5,12x
EV / EBITDA 8,65x 8,60x
Yield (DPS / Price) 3,01% 3,26%
Price to book (Price / BVPS) 3,73x 3,26x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 52,5% 53,1%
operating Leverage (Delta EBIT / Delta Sales) -1,66x 10,9x
Net Margin (Net Profit / Revenue) 31,1% 33,4%
ROA (Net Profit / Asset) 11,3% 11,7%
ROE (Net Profit / Equities) 49,4% 57,1%
Rate of Dividend 45,1% 44,9%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   2,74% 3,06%
Cash Flow / Sales 47,6% 45,3%
Capital Intensity (Assets / Sales) 2,76x 2,86x
Financial Leverage (Net Debt / EBITDA) 0,97x 0,91x
EPS & Dividend